This is an exciting and important time in brain cancer research, with researchers and clinicians exploring novel avenues and making steady progress each day. To continue to move the field forward and bring these advancements to the patients who need them, we must break down the barriers--financial, professional or institutional--that can limit progress, and instead bring together the best ideas and resources from the worlds of medicine, academia, government and business.
You gift will help foster collaboration across institutional lines and hasten a cure for brain cancer. To accelerate the transition of therapies into clinical studies for patients, ABC² has initiated a strategic collaboration, the ABC² Clinical Network. It is composed of four leading neuro-oncology centers and clinical investigators who work together to: provide guidance and counsel to the sponsors of drug therapies (particularly in the early stages of designing clinical trials), assist ABC² in evaluating potential drug therapies or the readiness of promising ones for clinical trials, and conduct trials of these therapies. The ABC² Clinical Network serves as a resource to patients and the scientific and medical communities. It is the vehicle through which ABC² translates successes in the lab into meaningful treament options for patients with brain cancer and their families.